Auris Medical Says Lincoln Park Capital Fund Will Subscribe For up to $15 Mln in Shares

Auris Medical Says Lincoln Park Capital Fund Will Subscribe For up to $15 Mln in Shares

Auris Medical (EARS), a a Swiss biopharmaceutical company, said Wednesday it has executed two share purchase agreements for up to $15 million with Lincoln Park Capital Fund. Under the deal, Auris may require the Chicago-based institutional investor to subscribe for up to $13.5 million of its common shares at market prices. Share subscriptions may take place over a 30-month period after the registration statement is declared effective by the SEC. […]

Read More ˃
AnaptysBio’s Price Target Nearly Doubled by RBC, Rating Kept at Outperform Speculative Risk

AnaptysBio’s Price Target Nearly Doubled by RBC, Rating Kept at Outperform Speculative Risk

AnaptysBio (ANAB) received a big boost to its price target from RBC Capital Markets after the clinical-stage biotechnology on Tuesday released encouraging proof-of-concept data from its phase 2a clinical trial of a treatment for atopic dermatitis, ANB020. The new price target from RBC is $79 per share, nearly double the firm’s prior price target on the stock of $40. This comes after the stock surged 101% in Tuesday’s session to […]

Read More ˃
Hong Kong Hang Seng Slips After Chief Executive Speech Fails To Address Land Issues

Hong Kong Hang Seng Slips After Chief Executive Speech Fails To Address Land Issues

The Hong Kong Hang Seng Index Wednesday opened higher, but then slipped on soft property stocks after Hong Kong Chief Executive Carrie Lam Cheng Yuet-ngor’s initial policy speech did not detail land-development measures, such as rezoning farmland to residential uses. Homebuilders in particular fell. Hong Kong is regarded as having some of the world’s most-expensive housing, especially in relation to incomes. In other news, the International Monetary Fund pegged mainland […]

Read More ˃
TransCanada Cancels Two Pipeline Projects Amid Regulatory Scrutiny

TransCanada Cancels Two Pipeline Projects Amid Regulatory Scrutiny

Pipeline operator TransCanada (TRP) will take C$1 billion ($790 million) charge in the fourth quarter after terminating plans for two pipelines in eastern Canada. The Canadian company said in a release it will end the planned Energy East and Eastern Mainline projects after a careful review of what it termed changed circumstances. Further details weren’t given. “In light of the project’s inability to reach a regulatory decision, no recoveries of […]

Read More ˃
Bund Yields Recover Earlier Losses

Bund Yields Recover Earlier Losses

Bund yields recovered earlier losses and are slightly higher on the day. Bunds have been underperforming throughout the day, as Spanish secession fears eased and Spanish markets bounced back. This saw Spanish bond yields leading a wider decline in peripherals, especially after the successful Spanish bond auction. At the same time, the reversal of intra-Eurozone safe haven flows saw Bunds underperforming Thursday and the German 10-year is now up 0.2 […]

Read More ˃